Deutsche Bank’s Rapport Therapeutics RAPP Stock Holding History
Bought
Maintained
Sold
Other funds holding RAPP
SL
Deutsche Bank's RAPP Position: Q3 2026 in Review
Deutsche Bank reduced its Rapport Therapeutics (RAPP) stake by 7% in Q3 2026, selling an estimated $97.9K and leaving 29,944 shares worth $1.01M. The position accounts for ﹤0.01% of the portfolio, ranked #2219.
Deutsche Bank first reported a position in RAPP in Q4 2024 and has held it in 8 quarters since. The position peaked at $1.34M in Q2 2026. 114 funds tracked by Wall St. Rank hold RAPP as of Q3 2026.
- Deutsche Bank held 29,944 shares of Rapport Therapeutics worth $1.01M as of Q3 2026.
- Deutsche Bank sold 2,268 Rapport Therapeutics shares in Q3 2026, an estimated $97.9K.
- Rapport Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q3 2026, its #2219 holding.
- Deutsche Bank first reported a position in Rapport Therapeutics in Q4 2024 and has held it in 8 quarters since.
- Deutsche Bank's Rapport Therapeutics position peaked at $1.34M in Q2 2026.
- 114 funds tracked by Wall St. Rank held Rapport Therapeutics as of Q3 2026.
Based on Deutsche Bank's 13F filing for Q3 2026, filed 6 Nov 2026.